Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
Ljungman
Per
P
Department of Hematology, Huddinge University Hospital, Karolinska Institutet, SE-14186 Stockholm, Sweden. per.ljungman@medhs.ki.se
D016913:Blood Component Transfusion / Q000009:adverse effects*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D016867:Immunocompromised Host; D007937:Leukapheresis; D007962:Leukocytes / Q000821:virology; D012307:Risk Factors